MENS (Jyong Biotech Ltd. Ordinary Shares) Stock Analysis - Hedge Fund Holdings

Jyong Biotech Ltd. Ordinary Shares (MENS) is a publicly traded Healthcare sector company. As of May 21, 2026, MENS trades at $2.09 with a market cap of $144.76M and a P/E ratio of 0.00. MENS moved -4.13% today. Year to date, MENS is -38.00%; over the trailing twelve months it is flat. Its 52-week range spans $1.43 to $67.00. Rallies surfaces MENS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns MENS stock?

Rallies tracks hedge fund and 13F ownership for MENS, including fund holders, share counts, and position changes when data is available.

MENS Key Metrics

Key financial metrics for MENS
MetricValue
Price$2.09
Market Cap$144.76M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$67.00
52-Week Low$1.43
Volume1
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest MENS News

MENS Analyst Consensus

MENS analyst coverage data. Average price target: $0.00.

Common questions about MENS

Who owns MENS stock?
Rallies tracks hedge fund and 13F ownership for MENS, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for MENS?
Yes. Rallies tracks hedge fund and 13F ownership data for MENS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is MENS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MENS. It does not provide personalized investment advice.
MENS

MENS